Agomab Therapeutics NV (Agomab) has announced positive interim results from 44 patients completing treatment in the ongoing ...

Pfizer Ltd has announced that the Scottish Medicines Consortium (SMC) has accepted Talzenna (talazoparib) in combination with enzalutamide for the treatment of adult patients with metastatic ...

NICE’s interim second draft guidance does not recommend lecanemab for use within the NHS in England and Wales at this time.

Octapharma has announced that, for the first time in almost 30 years, NHS patients are receiving medicines made from ...

Centauri Therapeutics Limited has announced the selection of its first clinical candidate for the ABX-01 programme. The ...

The Safety Review Committee (SRC) has confirmed the end of the Dose Escalation phase and the start of the cohort expansion ...

To reduce waiting lists and enhance patient communication, Rotherham NHS Foundation Trust has adopted Netcall’s Liberty for ...

Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee Kenvue’s business in the ...

A new UK study has highlighted the critical role of GP data in understanding atrial fibrillation (AF), the most common form of abnormal heart rhythm. The research led by Oxford Population Health and ...

The US Food and Drug Administration (FDA) has approved Deciphera Pharmaceuticals’ Romvimza (vimseltinib) to treat adults with symptomatic tenosynovial giant cell tumours (TGCTs). The drug has been ...

Carbogen Amcis has appointed Stephan Fritschi, who is currently serving as the company’s Chief Alliance Officer and Deputy CEO, as Chief Executive Officer (CEO). Fritschi will take on his new role at ...

Baxter has appointed Brent Shafer as Chair and Interim CEO Baxter International has appointed Brent Shafer, who has been serving as the company’s Lead Independent Director, as Chair and Interim Chief ...